ATRIPLA

600/200/245 Milligram Film Coated Tablet

Bristol-Myers Squibb Pharmaceuticals ucEU/1/07/430/001

Main Information

Trade NameATRIPLA
Active SubstancesEFAVIRENZ
EMTRICITABINE
TENOFOVIR DISOPROXIL FUMARATE
Strength600/200/245 Milligram
Dosage FormFilm Coated Tablet
Licence HolderBristol-Myers Squibb Pharmaceuticals uc
Licence NumberEU/1/07/430/001

Group Information

ATC CodeJ05AR06 emtricitabine, tenofovir disoproxil and efavirenz

Status

Authorised/WithdrawnAuthorised
Licence Issued13/12/2007
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back